Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the ...
TD Cowen raised the firm’s price target on DraftKings (DKNG) to $60 from $51 and keeps a Buy rating on the shares. The firm raised its ...
Output for Diamondback Energy nearly doubled in the fourth quarter as the US operator beat analyst expectations for its final ...
MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced ...
In a report released today, Josh Jennings from TD Cowen maintained a Hold rating on Becton Dickinson (BDX – Research Report), with a price ...
Cowen notes that Microsoft is citing construction delays and lack of access to power as excuses for trying to get out of its ...
Oliver Chen, TD Cowen senior retail analyst, joins 'Money Movers' to discuss Wall Street's reaction to Walmart's quarterly ...
TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 class of weight loss/obesity drugs could reach $139B by 2030, indicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results